Hubei Kailong Chemical Group Co Ltd

Hubei Kailong Chemical Group Co Ltd maintains a debt-to-equity ratio of 1.26, indicating a moderate reliance on debt financing. The company's liquidity is assessed as medium, with a current ratio of 0.82, suggesting that its current liabilities exceed its current assets. This implies potential short-term liquidity constraints, particularly if cash flow from operations is insufficient to meet immediate obligations.

Profitability metrics show a return on equity (ROE) of 1.58% and a return on assets (ROA) of 0.47%, both of which are below the typical thresholds for strong performance in the commodity chemicals industry. These figures suggest that the company is generating relatively low returns relative to its equity and asset base, which may indicate inefficiencies or weak pricing power in its core operations.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes in China. The absence of segment or geographic breakdown in the financial data limits the ability to assess the resilience of different parts of the business.

Looking ahead, the company's growth trajectory appears modest. Based on the most recent financial data, there is no indication of significant revenue growth in the current fiscal year. The capital expenditure of -87.08 million CNY suggests a reduction in investment in new projects or capacity expansion, which may signal a conservative approach to growth or financial constraints.

The risk assessment highlights a key flag: the company has negative net cash after subtracting total debt, which could pose a liquidity risk. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. However, the company's reliance on long-term debt (3.05 billion CNY) may increase financial risk if interest rates rise or if the company faces difficulties in refinancing.

Recent events include the disclosure of a last actual EPS of 0.14 CNY, as reported by analysts. This figure provides a baseline for earnings performance but does not indicate a clear upward or downward trend. The absence of recent filings or transcripts limits the ability to assess management commentary or strategic direction.

Hubei Kailong Chemical Group Co Ltd (002783.SZ) has been formally classified within the Chemicals activity and Basic Materials economic sector, marking a significant structural update to its corporate profile. This taxonomy classification, identified as a medium-severity change, establishes the fundamental operational context for the company, aligning its market identity with the broader basic materials industry. Concurrently, the company’s risk assessment framework has been initialized with specific metrics. The dilution risk is now rated as low, indicating a stable capital structure with minimal threat of share value erosion from new issuances. This low severity rating suggests that existing shareholders face limited immediate pressure from equity dilution. In contrast, the liquidity risk assessment has been set at a medium level. This classification highlights a moderate degree of uncertainty regarding the company’s ability to meet short-term financial obligations, a factor that investors in the basic materials sector typically monitor closely given the cyclical nature of cash flows in this industry. These updates provide a clearer baseline for analyzing Hubei Kailong Chemical Group’s financial health and operational positioning. With the company now categorized under Chemicals and Basic Materials, and its key risk factors of dilution and liquidity explicitly defined, stakeholders have a more structured foundation for evaluating future performance against sector benchmarks.

Free cash flow surged 107% year-over-year, demonstrating strong recent cash generation capabilities.

Cash conversion ratio of 6.16 ranks as best-in-class compared to the cohort median of 1.1.

Revenue grew at a 6.5% compound annual growth rate over the four-year period ending FY0.

Operating income increased 1.8% year-over-year, showing resilience despite a slight revenue decline.

Debt-to-equity ratio of 1.26 places the company in the bottom quartile of its cohort.

Return on equity of 1.6% lags significantly behind the cohort median of 3.6%.

The company faces high credit risk according to the provided risk flag assessment.

Net margin of 4.0% falls below the commodity chemicals cohort median of 4.2%.

Revenue declined 3.9% year-over-year, indicating a contraction in top-line sales growth.

Revenue ¥975.3M, −12,7% YoY; Operating income −32,1% YoY.

• ▍Revenue ¥975.3M, −12,7% YoY
• ▍Operating income −32,1% YoY
• ▍Net income −79,7% YoY
• ▍Net margin 0.8%

Revenue ¥827.9M, −11,1% YoY; Operating income −10,9% YoY.

• ▍Revenue ¥827.9M, −11,1% YoY
• ▍Operating income −10,9% YoY
• ▍Net income −39,9% YoY
• ▍Net margin 3.4%

Revenue ¥976.9M, +1,4% YoY; Operating income +60,6% YoY.

• ▍Revenue ¥976.9M, +1,4% YoY
• ▍Operating income +60,6% YoY
• ▍Net income +85,1% YoY
• ▍Net margin 7.3%

Revenue ¥3.41B, +23,4% YoY; Operating income +137,8% YoY.

• ▍Revenue ¥3.41B, +23,4% YoY
• ▍Operating income +137,8% YoY
• ▍Net income +133,8% YoY
• ▍Free cash flow +119,4% YoY
• ▍Net margin 3.9%

Revenue ¥2.76B; Operating income -¥479.4M.

• ▍Revenue ¥2.76B
• ▍Operating income -¥479.4M
• ▍Net margin -14.3%